Porcupine inhibition alleviates excessive bone formation in osteopathia striata with cranial sclerosis

Osteopathia striata with cranial sclerosis (OSCS) is a rare osteosclerotic disorder caused by mutations of AMER1, a negative regulator of the Wnt signaling pathway. These mutations lead to excessive osteoblast activity and bone hypertrophy, often resulting in cranial nerve compression. In the absence of targeted therapies, we explored Wnt inhibition as a potential treatment strategy. This study aimed to (i) characterize the cellular and histopathological features of OSCS human bone tissue, (ii) analyze the skeletal phenotype of an OSCS mouse model, and (iii) evaluate the therapeutic potential of LGK-974, a porcupine inhibitor that blocks Wnt ligand secretion and signaling. Histological analyses and primary osteoblast cultures from bone samples of a patient living with OSCS revealed increased trabecular thickness and reduced bone marrow adiposity, alongside enhanced osteoblast differentiation and mineralization. The OSCS murine model Prx1-Cre+; Amer1flox/Y recapitulated partly the human phenotype, with elevated cortical and trabecular bone mass due to increased bone formation by increasing osteoblast number. Transcriptomic profiling showed upregulation of Wnt & TGF-β signaling. Administration of LGK-974 significantly reduced bone mass and microarchitectural parameters by decreasing both osteoblast number and function, while promoting osteoclastogenesis. Transcriptomic changes included downregulation of Wnt and MAPK target genes, and upregulation of adipogenesis genes. In summary, AMER1 loss-of-function induces bone sclerosis by driving precursor cells toward early osteogenic differentiation. This phenotype results, at least partly, from ligand-dependent Wnt signaling, as demonstrated by the ability of LGK-974 to mitigate the excessive bone formation. Porcupine inhibitors may therefore represent a potential therapeutic strategy for orphan sclerosing bone disorders.

Authors

Institutions

Publication Details

Journal
Journal of Bone and Mineral Research
Published
2026-11-17
DOI
https://doi.org/10.1093/jbmr/zjag160
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Porcupine inhibition alleviates excessive bone formation in osteopathia striata with cranial sclerosis

Bertrand Baussart, Thomas Funck‐Brentano, Martine Esther Cohen-Solal, Clément Nachef et al.
2 links
Journal of Bone and Mineral Research
Bone Metabolism and Diseases
article

Porcupine inhibition alleviates excessive bone formation in osteopathia striata with cranial sclerosis

Bertrand Baussart, Thomas Funck‐Brentano, Martine Esther Cohen-Solal, Clément Nachef, Arnaud Vanjak, M Zarka, S Thomasseau, M Binvignat, M Bourmaud, A E Coudert
article en

Abstract

Osteopathia striata with cranial sclerosis (OSCS) is a rare osteosclerotic disorder caused by mutations of AMER1, a negative regulator of the Wnt signaling pathway. These mutations lead to excessive osteoblast activity and bone hypertrophy, often resulting in cranial nerve compression. In the absence of targeted therapies, we explored Wnt inhibition as a potential treatment strategy. This study aimed to (i) characterize the cellular and histopathological features of OSCS human bone tissue, (ii) analyze the skeletal phenotype of an OSCS mouse model, and (iii) evaluate the therapeutic potential of LGK-974, a porcupine inhibitor that blocks Wnt ligand secretion and signaling. Histological analyses and primary osteoblast cultures from bone samples of a patient living with OSCS revealed increased trabecular thickness and reduced bone marrow adiposity, alongside enhanced osteoblast differentiation and mineralization. The OSCS murine model Prx1-Cre+; Amer1flox/Y recapitulated partly the human phenotype, with elevated cortical and trabecular bone mass due to increased bone formation by increasing osteoblast number. Transcriptomic profiling showed upregulation of Wnt & TGF-β signaling. Administration of LGK-974 significantly reduced bone mass and microarchitectural parameters by decreasing both osteoblast number and function, while promoting osteoclastogenesis. Transcriptomic changes included downregulation of Wnt and MAPK target genes, and upregulation of adipogenesis genes. In summary, AMER1 loss-of-function induces bone sclerosis by driving precursor cells toward early osteogenic differentiation. This phenotype results, at least partly, from ligand-dependent Wnt signaling, as demonstrated by the ability of LGK-974 to mitigate the excessive bone formation. Porcupine inhibitors may therefore represent a potential therapeutic strategy for orphan sclerosing bone disorders.

Journal of Bone and Mineral Research
Inserm (FR), Université Paris Cité (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Saint-Antoine (FR), Bioscar (FR), Hôpital Lariboisière (FR), Immunologie - Immunopathologie - Immunothérapie (FR)
Office of the Civil Service Commission
Good health and well-being
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon